Patents by Inventor Stephen Dawe

Stephen Dawe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED T-CELLS FOR USE IN THE TREATMENT OF BLADDER CANCER
    Publication number: 20260083849
    Abstract: The disclosure relates to a method of treating bladder cancer, and to a population of modified immunoresponsive cells expressing a heterologous TCR for use in such method.
    Type: Application
    Filed: September 7, 2023
    Publication date: March 26, 2026
    Inventors: Stephen DAWE, Alejandro GARCIA-CONSUEGRA LÓPEZ-PICAZO, José María SARO SUAREZ
  • MODIFIED T-CELLS FOR USE IN THE TREATMENT OF GASTROESOPHAGEAL CANCER
    Publication number: 20260069692
    Abstract: The disclosure relates to a method of treating gastroesophageal cancer, and to a population of modified T cells expressing a heterologous TCR for use in such method.
    Type: Application
    Filed: September 7, 2023
    Publication date: March 12, 2026
    Inventors: Stephen DAWE, Alejandro GARCIA-CONSUEGRA LÓPEZ-PICAZO, José María SARO SUAREZ
  • MODIFIED T-CELLS FOR USE IN THE TREATMENT OF HEAD AND NECK CANCER
    Publication number: 20260069691
    Abstract: The disclosure relates to a method of treating head and neck cancer, and to a population of modified immunoresponsive cells expressing a heterologous TCR for use in such method.
    Type: Application
    Filed: September 7, 2023
    Publication date: March 12, 2026
    Inventors: Stephen DAWE, Alejandro GARCIA-CONSUEGRA LÓPEZ-PICAZO, José María SARO SUAREZ
  • Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control group
    Patent number: 11508483
    Abstract: The present invention relates to a method of identifying a subgroup of patients suffering from diffuse cutaneous systemic sclerosis (dcSSc) which subgroup of patients benefits from a treatment with at least one sGC stimulator and/or sGC activator in a higher degree than patients not belonging to this subgroup.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: November 22, 2022
    Assignee: Adverio Pharma GmbH
    Inventors: Peter Sandner, Melanie Hemmrich, Janethe De Oliveira Pena, Stephen Dawe
  • Method of Identifying a Subgroup of Patients Suffering from DcSSc which Benefits from a Treatment with sGC Stimulators and sGC Activators in a Higher Degree than a Control Group
    Publication number: 20190371469
    Abstract: The present invention relates to a method of identifying a subgroup of patients suffering from diffuse cutaneous systemic sclerosis (dcSSc) which subgroup of patients benefits from a treatment with at least one sGC stimulator and/or sGC activator in a higher degree than patients not belonging to this subgroup.
    Type: Application
    Filed: May 28, 2019
    Publication date: December 5, 2019
    Applicant: ADVERIO PHARMA GMBH
    Inventors: Peter SANDNER, Melanie HEMMRICH, Janethe DE OLIVEIRA PENA, Stephen DAWE
  • ROCK BOLT
    Publication number: 20070217869
    Abstract: A rock bolt (10) which includes An elongate tubular member (18), which is formed with an inlet (22) through which a pressurized fluid can pass, into an interior of the tubular member (18), thereby to expand the tubular member (18) in a radial direction, an elongate shank (12) with a first end (14) which is secured to the tubular member (18) and a second end (16), and an expansion unit (26) which has a wedge-shaped member (44) at the second end (16) of the shank (12).
    Type: Application
    Filed: October 28, 2004
    Publication date: September 20, 2007
    Applicant: Grinaker-LTA Limited
    Inventor: Stephen Dawe